FGFR

CAT # Sunan samfur Bayani
Saukewa: CPD100464 Erdafitinib Erdafitinib, wanda kuma aka sani da JNJ-42756493, mai ƙarfi ne kuma zaɓaɓɓe na baka, mai hana mai karɓar haɓakar girma na pan fibroblast (FGFR) tare da yuwuwar aikin antineoplastic. Bayan gudanar da baki, JNJ-42756493 yana ɗaure zuwa kuma yana hana FGFR, wanda zai iya haifar da hanawar hanyoyin watsa siginar da ke da alaka da FGFR kuma ta haka ne hana yaduwar ƙwayar ƙwayar cuta da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta a cikin FGFR-overexpressing ƙwayoyin tumor. FGFR, wanda aka haɓaka a cikin nau'ikan ƙwayoyin ƙwayar cuta da yawa, shine mai karɓar tyrosine kinase mai mahimmanci don haɓaka ƙwayar ƙwayar cuta, rarrabuwa da rayuwa.
Saukewa: CPD3618 TAS-120 TAS-120 shine mai hanawa ta baki na mai karɓar haɓakar haɓakar fibroblast (FGFR) tare da yuwuwar aikin antineoplastic. FGFR inhibitor TAS-120 zaɓaɓɓe kuma ba tare da jujjuyawa ba yana ɗaure zuwa kuma yana hana FGFR, wanda zai iya haifar da hanawa duka hanyar watsa siginar siginar FGFR da haɓakar ƙwayar ƙwayar cuta, da haɓakar mutuwar ƙwayoyin cuta a cikin FGFR-overexpressing ƙwayoyin tumor. FGFR shine mai karɓar tyrosine kinase mai mahimmanci don haɓaka ƙwayar ƙwayar ƙwayar cuta, bambance-bambance da rayuwa kuma an daidaita maganarsa a yawancin nau'in ƙwayar ƙwayar cuta.
Saukewa: CPDB1093 Derazantinib; ARQ-087 Derazantinib, wanda kuma aka sani da ARQ-087, shine mai hanawa ta baki na mai karɓar haɓakar haɓakar fibroblast (FGFR) tare da yuwuwar aikin antineoplastic.
Saukewa: CPDB0942 BLU-554 BLU-554 shine mai hanawar fibroblast girma factor 4 (FGFR4) mai hanawa mai yuwuwa don maganin cututtukan hanta da cholangiocarcinoma.
Saukewa: CPD0999 H3B-6527 H3B-6527 (H3 Biomedicine) mai hanawa FGFR4 ne mai zaɓe mai ƙarfi tare da aiki mai ƙarfi na antitumor a cikin FGF19 haɓakar layukan salula da beraye.
Saukewa: CPD0997 Saukewa: FGF401 FGF-401 mai hanawa ne na FGFR4 da aka samo daga patent WO2015059668A1, misali misali 83; yana da IC50 na 1.9 nM.
Saukewa: CPDB0053 Saukewa: AZD4547 AZD 4547 shine mai zaɓin zaɓi na mai karɓa na fibroblast girma factor receptor (FGFR) tyrosine kinase tare da ƙimar IC50 na 0.2, 2.5, da 1.8 nM don FGFR1, 2, da 3, bi da bi.
Saukewa: CPD3610 BLU-9931 BLU9931 mai ƙarfi ne, zaɓi, kuma mai hanawa FGFR4 wanda ba zai iya jurewa ba tare da IC50 na 3 nM, game da 297-, 184-, da 50-ninka zaɓi akan FGFR1/2/3, bi da bi.
da

Tuntube Mu

Tambaya

Sabbin Labarai

  • Manyan Abubuwa 7 A cikin Binciken Magunguna A cikin 2018

    Manyan Abubuwa 7 A Cikin Binciken Magunguna Na...

    Kasancewar kasancewa ƙarƙashin matsin lamba don yin gasa a cikin yanayi mai ƙalubale na tattalin arziki da fasaha, dole ne kamfanonin harhada magunguna da fasahar kere-kere su ci gaba da haɓaka cikin shirye-shiryensu na R&D don ci gaba ...

  • ARS-1620: Sabuwar mai hanawa don KRAS-mutant cancers

    ARS-1620: Sabuwar mai hanawa don K ...

    A cewar wani binciken da aka buga a cikin Cell, masu bincike sun kirkiro wani takamaiman mai hanawa don KRASG12C mai suna ARS-1602 wanda ya haifar da koma baya a cikin mice. "Wannan binciken yana ba da shaida a cikin vivo shaida cewa mutant KRAS na iya zama ...

  • AstraZeneca yana karɓar haɓakar tsari don magungunan oncology

    AstraZeneca yana karɓar haɓaka tsari don ...

    AstraZeneca ta sami haɓaka ninki biyu don fayil ɗin cutar sankara a ranar Talata, bayan hukumomin Amurka da na Turai sun karɓi ƙa'idodin ƙa'idodin magungunanta, matakin farko na samun amincewar waɗannan magunguna. ...

WhatsApp Online Chat!